Organon Shareholders Approve Merger With Sun Pharmaceutical Holdings
Shareholders of Organon & Co. approved the proposed merger with Sun Pharmaceutical Holdings USA, Inc., marking a significant step in the deal process. The transaction will see Sun Pharma's subsidiary merge with and into Organon, making it a wholly owned subsidiary under Sun Pharma USA.
Tickers: $OGN
Topics: corporate merger Organon & Co. shareholder vote Sun Pharmaceutical Holdings USA